| Literature DB >> 35688382 |
Kyle Fulghum1, Helen E Collins2, Steven P Jones2, Bradford G Hill3.
Abstract
Although the structural and functional effects of exercise on the heart are well established, the metabolic changes that occur in the heart during and after exercise remain unclear. In this study, we used metabolomics to assess time-dependent changes in the murine cardiac metabolome following 1 session of treadmill exercise. After the exercise bout, we also recorded blood lactate, glucose, and ketone body levels and measured cardiac mitochondrial respiration. In both male and female mice, moderate- and high-intensity exercise acutely increased blood lactate levels. In both sexes, low- and moderate-intensity exercise augmented circulating 3-hydroxybutryrate levels immediately after the exercise bout; however, only in female mice did high-intensity exercise increase 3-hydroxybutyrate levels, with significant increases occurring 1 h after the exercise session. Untargeted metabolomics analyses of sedentary female and male hearts suggest considerable sex-dependent differences in basal cardiac metabolite levels, with female hearts characterized by higher levels of pantothenate, pyridoxamine, homoarginine, tryptophan, and several glycerophospholipid and sphingomyelin species and lower levels of numerous metabolites, including acetyl coenzyme A, glucuronate, gulonate, hydroxyproline, prolyl-hydroxyproline, carnosine, anserine, and carnitinylated and glycinated species, as compared with male hearts. Immediately after a bout of treadmill exercise, both male and female hearts had higher levels of corticosterone; however, female mice showed more extensive exercise-induced changes in the cardiac metabolome, characterized by significant, time-dependent changes in amino acids (e.g., serine, alanine, tyrosine, tryptophan, branched-chain amino acids) and the ketone body 3-hydroxybutyrate. Results from experiments using isolated cardiac mitochondria suggest that high-intensity treadmill exercise does not acutely affect respiration or mitochondrial coupling; however, female cardiac mitochondria demonstrate generally higher adenosine diphosphate sensitivity compared with male cardiac mitochondria. Collectively, these findings in mice reveal key sex-dependent differences in cardiac metabolism and suggest that the metabolic network in the female heart is more responsive to physiological stress caused by exercise.Entities:
Keywords: Ketone bodies; Metabolomics; Mitochondria; Physical activity; Sex differences
Mesh:
Substances:
Year: 2022 PMID: 35688382 PMCID: PMC9338340 DOI: 10.1016/j.jshs.2022.06.001
Source DB: PubMed Journal: J Sport Health Sci ISSN: 2213-2961 Impact factor: 13.077
Fig. 1Exercise intensity affects circulating substrate levels. Mice were subjected to low-, moderate-, and high-intensity exercise followed by measurement of circulating substrates immediately after the exercise bout. (A) Schematic of study design; (B) Distance run to exhaustion; (C) Work performed during the exercise session; Measurements of (D) circulating lactate, (E) glucose, and (F) 3-hydroxybutyrate at the end of exercise bout. n = 5 mice per group. * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001, #p < 0.05 female vs. male, two-way ANOVA with Bonferroni's post hoc test (B–F). ANOVA = analysis of variance; gp = group.
Fig. 2Time-dependent changes in circulating substrates after 1 bout of high-intensity exercise. Mice were subjected to 1 bout of high-intensity exercise (i.e., exercise capacity test) followed by measurement of circulating substrates immediately, 1 h, and 24 h after the exercise bout. (A) Schematic of study design; (B) Distance run to exhaustion; (C) Work performed during the exercise session; and measurements of circulating (D) lactate, (E) glucose, and (F) 3-hydroxybutrate. n = 4–5 mice per group. ** p < 0.01, *** p < 0.001, two-way ANOVA with Bonferroni's post hoc test (B, C); * p < 0.05, ** p < 0.01, ***p < 0.001, #p < 0.05 female vs. male, two-way ANOVA with Bonferroni's post hoc test for acute sedentary ctrl, acute exe, and 1 h post exe group; Student's t test for 24 h sedentary ctrl and 24 h post exe group (D–F). ANOVA = analysis of variance; ctrl = control; exe = exercise; gp = group.
Fig. 3Biological sex influences baseline cardiac metabolite abundances. Unbiased metabolomics of male and female sedentary mice. (A) Dot plot showing 69 significantly different (FDR < 0.10) metabolites between male and female hearts; (B) Partial least-squares discriminant analysis; and (C) Variable importance plot assessing metabolite contribution to the PLS-DA model. n = 4–5 mice per group. F = female; FDR = false discovery rate; GPE = glycerophosphoethanolamine; M = male; mz = mass to charge ratio; PLS-DA = partial least-squares discriminant analysis; rt = retention time; VIP = variable importance plot.
Significantly different metabolites in male vs. female mouse hearts under sedentary conditions.
| Metabolite | HMDB | FDR | Relative fold change (female/male) | |
|---|---|---|---|---|
| 1-(1-enyl-palmitoyl)-2-arachidonoyl-GPE (P-16:0/20:4)* | HMDB0011352 | 0.058985 | 0.0049448 | 1.8496 |
| 1-(1-enyl-palmitoyl)-2-palmitoyl-GPC (P-16:0/16:0)* | HMDB0011206 | 0.098967 | 0.01363 | 1.5773 |
| 1-(1-enyl-stearoyl)-2-arachidonoyl-GPE (P-18:0/20:4)* | HMDB0005779 | 0.042021 | 0.0026001 | 2.4368 |
| 1,2-dipalmitoyl-GPC (16:0/16:0) | HMDB0000564 | 0.032553 | 0.0017543 | 1.1384 |
| 1,2-dipalmitoyl-GPE (16:0/16:0)* | HMDB0008923 | 0.085015 | 0.010012 | 1.8653 |
| 1,5-anhydroglucitol (1,5-AG) | HMDB0002712 | 0.026958 | 0.001071 | 0.74591 |
| 18-methylnonadecanoate (i20:0) | 0.076639 | 0.0077645 | 0.64032 | |
| 1-palmitoyl-2-oleoyl-GPE (16:0/18:1) | HMDB0005320 | 0.064962 | 0.0057053 | 1.7594 |
| 1-palmitoyl-2-stearoyl-GPC (16:0/18:0) | HMDB0007970 | 0.080764 | 0.0088663 | 1.4596 |
| 1-palmitoyl-2-stearoyl-GPE (16:0/18:0) * | HMDB08925 | 0.095363 | 0.012943 | 2.2263 |
| 1-stearoyl-2-arachidonoyl-GPC (18:0/20:4) | HMDB0008048 | 0.048158 | 0.0034605 | 1.388 |
| 1-stearoyl-2-oleoyl-GPE (18:0/18:1) | HMDB0008993 | 0.076639 | 0.0081075 | 2.1764 |
| 2,4-dihydroxybutyrate | HMDB0000360 | 0.017783 | 0.0004969 | 0.45552 |
| 2-hydroxybutyrate/2-hydroxyisobutyrate | HMDB0000729 | 0.032046 | 0.0016631 | 0.57854 |
| 5,6-dihydrouridine | HMDB0000497 | 0.017806 | 0.0005452 | 2.0412 |
| Acetyl-CoA | HMDB0001206 | 0.085608 | 0.010594 | 0.48448 |
| Alpha-hydroxyisovalerate | HMDB0000407 | 0.0012158 | 2.43E-06 | 0.17297 |
| Anserine | HMDB0000194 | 0.0023567 | 1.42E-05 | 0.45349 |
| Arachidoylcarnitine (C20)* | HMDB0006460 | 0.052613 | 0.0040478 | 0.28036 |
| Ascorbic acid 3-sulfate* | 0.041488 | 0.0024843 | 1.8814 | |
| Betaine | HMDB0000043 | 0.069631 | 0.0065322 | 0.75022 |
| Bicine | HMDB0011727 | 0.093213 | 0.012466 | 1.922 |
| Carnosine | HMDB0000033 | 0.0028901 | 2.88E-05 | 0.43553 |
| Ceramide (d18:2/24:1, d18:1/24:2)* | 0.092441 | 0.011879 | 1.6207 | |
| C-glycosyltryptophan | HMDB0240296 | 0.026958 | 0.0010465 | 0.49009 |
| Deoxycarnitine | HMDB0001161 | 0.052613 | 0.0040956 | 0.78712 |
| Diacylglycerol (16:1/18:2 [2], 16:0/18:3 [1])* | 0.076639 | 0.0078431 | 2.2958 | |
| Equol sulfate | 0.084622 | 0.0096276 | 0.20255 | |
| Erucoylcarnitine (C22:1)* | 0.032046 | 0.0016039 | 0.37269 | |
| Gamma-glutamylvaline | HMDB0011172 | 0.017806 | 0.0005687 | 0.33472 |
| Glucuronate | HMDB0000127 | 0.026958 | 0.0011838 | 0.52161 |
| Glycerophosphoethanolamine | HMDB0000114 | 0.092559 | 0.012193 | 0.64594 |
| Gulonate* | HMDB0003290 | 0.031793 | 0.0014596 | 0.42189 |
| Hexanoylglycine (C6) | HMDB0000701 | 0.0023567 | 1.88E-05 | 0.18636 |
| Homoarginine | HMDB0000670 | 0.017783 | 0.0004852 | 1.7604 |
| Hydroxypalmitoyl sphingomyelin (d18:1/16:0(OH)) | 0.052069 | 0.0038454 | 1.3499 | |
| Hydroxyproline | 0.067516 | 0.0061991 | 0.60524 | |
| Imidazole lactate | HMDB0002320 | 0.0034709 | 4.16E-05 | 0.23819 |
| Indolelactate | HMDB0000671 | 0.0043038 | 6.01E-05 | 1.9888 |
| Isovalerylglycine | HMDB00678 | 0.0023567 | 1.52E-05 | 0.27293 |
| Maleate | HMDB0000176 | 0.076639 | 0.0079138 | 0.5487 |
| Methylsuccinate | HMDB0001844 | 0.058985 | 0.0048017 | 1.2955 |
| N,N,N-trimethyl-5-aminovalerate | 0.025865 | 0.0008777 | 2.105 | |
| N-acetylglutamate | HMDB0001138 | 0.092441 | 0.011732 | 0.78083 |
| N-acetylglutamine | HMDB0006029 | 0.014512 | 0.0002897 | 0.51854 |
| N-acetylglycine | HMDB0000532 | 0.0064952 | 0.0001095 | 0.52201 |
| N-acetylleucine | HMDB0011756 | 0.038054 | 0.0022027 | 0.59356 |
| N-stearoyl-sphingadienine (d18:2/18:0)* | 0.026958 | 0.0010791 | 2.0202 | |
| N-stearoyl-sphingosine (d18:1/18:0)* | HMDB0004950 | 0.026958 | 0.0011398 | 1.868 |
| N-stearoyltaurine | 0.092441 | 0.011993 | 0.75217 | |
| Oleoyl-oleoyl-glycerol (18:1/18:1) [2]* | HMDB0007218 | 0.073131 | 0.0070066 | 2.279 |
| Orotate | HMDB0000226 | 0.083315 | 0.0093126 | 0.59776 |
| Orotidine | HMDB0000788 | 0.066986 | 0.0060167 | 0.73148 |
| Pantothenate (Vitamin B5) | HMDB0000210 | 0.017429 | 0.0003993 | 3.9236 |
| Phenylacetylglycine | HMDB0000821 | 0.048158 | 0.0033927 | 0.52079 |
| Prolyl-hydroxyproline | 0.058985 | 0.0049184 | 0.44851 | |
| Pseudouridine | HMDB0000767 | 0.017429 | 0.0004175 | 1.7891 |
| Pyridoxamine | HMDB0001431 | 0.032046 | 0.0016585 | 1.4963 |
| Serine | HMDB0000187 | 0.085608 | 0.01058 | 1.3084 |
| Sphingomyelin (d18:0/18:0, d19:0/17:0)* | HMDB0012087 | 0.077799 | 0.0083855 | 1.9696 |
| Sphingomyelin (d18:1/14:0, d16:1/16:0)* | HMDB0012097 | 0.062539 | 0.0053676 | 1.5269 |
| Sphingomyelin (d18:1/17:0, d17:1/18:0, d19:1/16:0) | 0.0064952 | 0.0001167 | 1.6125 | |
| Sphingomyelin (d18:1/18:1, d18:2/18:0) | HMDB0012101 | 0.047581 | 0.003229 | 1.4112 |
| Stearoyl sphingomyelin (d18:1/18:0) | HMDB0001348 | 0.038054 | 0.0021945 | 1.4065 |
| Thiamin diphosphate | HMDB0001372 | 0.076639 | 0.0080241 | 0.72402 |
| Threonine | HMDB0000167 | 0.085608 | 0.010285 | 1.2521 |
| Tricosanoyl sphingomyelin (d18:1/23:0)* | HMDB0012105 | 0.085015 | 0.0098422 | 1.6406 |
| Triethanolamine | HMDB0032538 | 0.046539 | 0.0030654 | 2.7857 |
| Tryptophan | HMDB0000929 | 0.046539 | 0.0029834 | 1.4203 |
Notes: Hearts from male and female FVB/NJ wild-type mice were freeze-clamped, and metabolites extracted from the hearts were subjected to LC/MS analysis. Raw area counts from each identified metabolite were log-transformed, autoscaled, and then subjected to t test analysis. Missing values were omitted from the analysis.
* indicates compounds that were not officially confirmed based on a standard, but whose identity matches the expected exact mass using the UHPLC/MS/MS2 accurate mass platform. Shown are those metabolites with an FDR value threshold of 0.10 or less. n = 4 female hearts and 5 male hearts per group.
Abbreviations: FDR = false discovery rate; GPC = glycerophosphocholine; GPE = glycerophosphoethanolamine; HMDB = human metabolome database; LC/MS = liquid chromatography/mass spectrometry; UHPLC/MS/MS = Ultra-high performance liquid chromatography/mass spectrometry/mass spectrometry.
Fig. 4Major metabolomic differences between male and female hearts. Metabolomic analyses highlighting the influence of sex on basal metabolite abundances in the hearts of sedentary mice. (A) Heatmap of top 50 significantly different metabolites; (B) Venn diagram displaying major metabolites and metabolite classes that differ based on sex; and (C) Pathway impact analysis. n = 4–5 mice per group. FDR = false discovery rate; GPC = glycerophosphocholine.
Fig. 5Changes in cardiac metabolite abundances following 1 session of exercise in female murine hearts. Female mice were subjected to 1 bout of high-intensity exercise and hearts were freeze-clamped immediately or 1 h after the exercise bout for unbiased metabolomic analyses. (A) Heatmap of the top 50 most changed metabolites in hearts from exercised versus sedentary female mice; bolded metabolites indicate FDR < 0.10 following one-way ANOVA; (B) Graphs of individual metabolites that showed the most prominent changes caused by exercise; (C) PLS-DA plot; (D) corresponding VIP plot; and (E) pathway impact analysis derived from most significantly changed metabolites. n = 4 female mice per group. 3-OHB = 3-hydroxybutyrate; ANOVA = analysis of variance; Exe = exercise; FDR = false discovery rate; GPC = glycerophosphocholine; GPI = glycosylphosphatidylinositol; PLS-DA = partial least-squares discriminant analysis; VIP = variable importance plot.
Fig. 6Male hearts demonstrate few significantly changed metabolites after a bout of high-intensity exercise. Male mice were subjected to one bout of high-intensity exercise and hearts were freeze-clamped immediately or 1 h after the exercise bout for unbiased metabolomic analyses. (A) Heatmap of the top 50 most changed metabolites in hearts from exercised and sedentary male mice; bolded metabolites indicate FDR < 0.10 following one-way ANOVA; (B) PLS-DA plot, and (C) corresponding VIP plot. n = 5 male mice per group. ANOVA = analysis of variance; CDP = Cytidine diphosphate; exe = exercise; FDR = False discovery rate; PLS-DA = partial least-squares discriminant analysis; VIP = variable importance plot.
Fig. 7Acute exercise has minimal effects on cardiac mitochondrial respiration. Male and female mice were subject to 1 bout of intense exercise followed immediately by isolation of cardiac mitochondria and respiration analyses using glutamate (5 mM), pyruvate (5 mM), succinate (5 mM), or octanoylcarnitine (100 µM) as substrate. (A) Distance run to exhaustion in the high-intensity exercise capacity test; (B) ADP was added to 1 mM to induce state 3 cardiac mitochondrial respiration under each substrate condition; (C) Oligomycin-induced state 4 respiration under each substrate condition; (D) Respiratory control ratio; and (E) ADP sensitivity of cardiac mitochondria provided with pyruvate (5 mM) as substrate and different concentrations of ADP (25–500 µM). n = 5 female mice and 3–5 male mice per group. #p < 0.05 female vs. male, two-way ANOVA with Bonferroni's post hoc test performed on B–D and a three-way ANOVA was used to test significance in E. ANOVA = analysis of variance; OCR = oxygen consumption rate.